Literature DB >> 15070486

Rett syndrome: a prototypical neurodevelopmental disorder.

Jeffrey L Neul1, Huda Y Zoghbi.   

Abstract

Rett syndrome, one of the leading causes of mental retardation and developmental regression in girls, is the first pervasive developmental disorder with a known genetic cause. The majority of cases of sporadic Rett syndrome are caused by mutations in the gene encoding methyl-CpG-binding protein 2 (MeCP2). MeCP2 binds methylated DNA and likely regulates gene expression and chromatin structure. Genotype/phenotype analysis revealed that the phenotypic spectrum of MECP2 mutations in humans is broader than initially suspected: Mutations have been discovered in Rett syndrome variants, mentally retarded males, and autistic children. A variety of in vivo and in vitro models has been developed that allow analysis of MeCP2 function and pathogenic studies of Rett syndrome. Because the neuropathology of Rett syndrome shares certain features with other neurodevelopmental disorders, a common pathogenic process may underlie these disorders. Thus, Rett syndrome is a prototype for the genetic, molecular, and neurobiological analysis of neurodevelopmental disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070486     DOI: 10.1177/1073858403260995

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  54 in total

Review 1.  Brief report: systematic review of Rett syndrome in males.

Authors:  Brian Reichow; Annie George-Puskar; Tara Lutz; Isaac C Smith; Fred R Volkmar
Journal:  J Autism Dev Disord       Date:  2015-10

2.  The Changing Face of Survival in Rett Syndrome and MECP2-Related Disorders.

Authors:  Daniel C Tarquinio; Wei Hou; Jeffrey L Neul; Walter E Kaufmann; Daniel G Glaze; Kathleen J Motil; Steven A Skinner; Hye-Seung Lee; Alan K Percy
Journal:  Pediatr Neurol       Date:  2015-06-26       Impact factor: 3.372

Review 3.  Transient receptor potential channels as novel effectors of brain-derived neurotrophic factor signaling: potential implications for Rett syndrome.

Authors:  Michelle D Amaral; Christopher A Chapleau; Lucas Pozzo-Miller
Journal:  Pharmacol Ther       Date:  2006-11-21       Impact factor: 12.310

4.  Progress in human genetics.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-12-07

5.  Brief report: MECP2 mutations in people without Rett syndrome.

Authors:  Bernhard Suter; Diane Treadwell-Deering; Huda Y Zoghbi; Daniel G Glaze; Jeffrey L Neul
Journal:  J Autism Dev Disord       Date:  2014-03

6.  Interference Resolved: Sorting out Picky Protocadherins in Epilepsy.

Authors:  Christina Gross
Journal:  Epilepsy Curr       Date:  2018 May-Jun       Impact factor: 7.500

7.  The Ferrier Lecture 1998. The molecular biology of consciousness investigated with genetically modified mice.

Authors:  Jean-Pierre Changeux
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-12-29       Impact factor: 6.237

Review 8.  Gestational hypoxia and epigenetic programming of brain development disorders.

Authors:  Qingyi Ma; Fuxia Xiong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2014-09-26       Impact factor: 7.851

9.  Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.

Authors:  Garilyn M Jentarra; Shannon L Olfers; Stephen G Rice; Nishit Srivastava; Gregg E Homanics; Mary Blue; Sakkubai Naidu; Vinodh Narayanan
Journal:  BMC Neurosci       Date:  2010-02-17       Impact factor: 3.288

10.  Reversal of neurological defects in a mouse model of Rett syndrome.

Authors:  Jacky Guy; Jian Gan; Jim Selfridge; Stuart Cobb; Adrian Bird
Journal:  Science       Date:  2007-02-08       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.